Approval · Notice of Compliance 8690 · 2007
TRINIPATCH: Notice of Compliance 8690
Issued April 3, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8690
- Date
- April 3, 2007
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- The removal of a statement from warning and precautions and contraindication sections and other revisions to the product monograph
- Therapeutic class
- Antianginal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRINIPATCH | Not yet assigned | — |
Medicinal ingredients
- NITROGLYCERIN 22.4 MG per PATCH
- NITROGLYCERIN 44.8 MG per PATCH
- NITROGLYCERIN 67.2 MG per PATCH